Drug-maker Valeant eyes small and large M&A deals

Thursday, 31 Oct 2013 | 9:17 AM ET

Oct 31 (Reuters) - Canada's Valeant Pharmaceuticals International Inc said on Thursday that it sees small, cash-based acquisitions likely in the near term, but is also interested in a "merger of equals" involving a swap of equity.

Chief Executive Michael Pearson said he thinks such a merger will happen, but is unsure of the timing.

  Price   Change %Change